A detailed history of Rtw Investments, LP transactions in Argenx Se stock. As of the latest transaction made, Rtw Investments, LP holds 654,430 shares of ARGX stock, worth $369 Million. This represents 5.66% of its overall portfolio holdings.

Number of Shares
654,430
Previous 654,430 -0.0%
Holding current value
$369 Million
Previous $281 Million 26.11%
% of portfolio
5.66%
Previous 4.7%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$356.01 - $451.55 $4.54 Million - $5.76 Million
-12,765 Reduced 1.91%
654,430 $281 Million
Q4 2023

Feb 14, 2024

BUY
$338.91 - $506.01 $54.2 Million - $81 Million
160,000 Added 31.55%
667,195 $254 Million
Q3 2023

Nov 14, 2023

BUY
$369.35 - $548.43 $9.23 Million - $13.7 Million
25,000 Added 5.18%
507,195 $249 Million
Q4 2022

Feb 14, 2023

BUY
$342.17 - $402.31 $5.13 Million - $6.03 Million
15,000 Added 3.21%
482,195 $183 Million
Q3 2022

Nov 14, 2022

BUY
$343.2 - $395.75 $8.43 Million - $9.72 Million
24,560 Added 5.55%
467,195 $165 Million
Q2 2022

Aug 15, 2022

BUY
$269.58 - $378.88 $28.5 Million - $40 Million
105,657 Added 31.35%
442,635 $168 Million
Q1 2022

May 16, 2022

BUY
$254.45 - $351.06 $4.97 Million - $6.86 Million
19,531 Added 6.15%
336,978 $106 Million
Q4 2021

Feb 14, 2022

BUY
$272.01 - $353.03 $48.2 Million - $62.5 Million
177,136 Added 126.25%
317,447 $111 Million
Q3 2021

Nov 15, 2021

BUY
$295.0 - $350.58 $32 Million - $38.1 Million
108,559 Added 341.9%
140,311 $42.4 Million
Q4 2019

Feb 14, 2020

BUY
$106.59 - $164.21 $25,155 - $38,753
236 Added 0.75%
31,752 $5.1 Million
Q3 2019

Nov 14, 2019

BUY
$113.31 - $150.51 $7,705 - $10,234
68 Added 0.22%
31,516 $3.59 Million
Q2 2019

Aug 14, 2019

BUY
$115.0 - $141.58 $84,410 - $103,919
734 Added 2.39%
31,448 $4.45 Million
Q1 2019

May 15, 2019

BUY
$98.85 - $134.59 $191,472 - $260,700
1,937 Added 6.73%
30,714 $3.83 Million
Q4 2018

Feb 14, 2019

BUY
$63.81 - $109.82 $122,770 - $211,293
1,924 Added 7.16%
28,777 $2.77 Million
Q3 2018

Nov 14, 2018

BUY
$75.5 - $96.63 $97,697 - $125,039
1,294 Added 5.06%
26,853 $2.04 Million
Q2 2018

Aug 14, 2018

BUY
$74.84 - $100.16 $7,633 - $10,216
102 Added 0.4%
25,559 $2.12 Million
Q1 2018

May 14, 2018

BUY
$56.95 - $85.19 $11,219 - $16,782
197 Added 0.78%
25,457 $2.05 Million
Q4 2017

Feb 14, 2018

BUY
$22.57 - $63.56 $7,989 - $22,500
354 Added 1.42%
25,260 $1.6 Million
Q3 2017

Nov 14, 2017

BUY
$19.81 - $22.61 $493,387 - $563,124
24,906
24,906 $563,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $31.2B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Rtw Investments, LP Portfolio

Follow Rtw Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rtw Investments, LP with notifications on news.